We reported the inhibitory effects of genistein, an inhibitor of tyrosine protein kinase (TPK), on ultraviolet B (UVB)-induced expression of c-fos and c-jun in SENCAR mouse skin. UVB irradiation substantially increased transcript levels of c-fos and c-jun mRNA in mouse skin. Topical application of genistein 60 min before UVB radiation reduced c-fos and c-jun expression in the mouse skin in dose-dependent manner. Inhibition was more pronounced in skin exposed to the low dose (5 kJ/m 2 ) than to the high dose (15 kJ/m 2 ) of UVB radiation. In addition, genistein exhibited more inhibition of c-fos than that of c-jun. Post-application of genistein after UVB exposure down-regulated the expressions of c-fos and c-jun, but to a lesser extent compared with pre-application. A431 human epidermoid carcinoma cells, which excessively express epidermal growth factor receptors (EGF-R), were used to investigate the possible mechanism of genistein's action. The results showed that genistein down-regulated the UVB-mediated phosphorylation of TPK-dependent EGF-R in a dose-dependent manner. We concluded that inhibition of UVB-induced c-fos and c-jun expression in mouse skin by genistein may, at least in part, result from the inhibition of TPK activities and down-regulation of EGF-R phosphorylation. Suppression of UVB-induced proto-oncogene expression in mouse skin suggests that genistein may serve as a potential preventative agent against photodamage and photocarcinogenesis.
Introduction
Ultraviolet B (UVB*) from sunlight has been long known as an etiological agent of human skin cancers. One of the proposed mechanisms is that UV radiation activates oncogenes that lead to the development of neoplasms. A group of proto-oncogenes, also termed 'immediate early genes', are known to be induced by a variety of agents which act through distinct signal transduction pathways, including the protein kinase C (PKC) pathway and the pathways following growth factor interaction with cellular receptors such as tyrosine protein kinases (TPK)-dependent epidermal growth factor receptor (EGF-R) (1) . Aberrant expression of these proto-oncogenes may transform a normal cell into a tumor cell and plays an important role in tumorigenesis (1) (2) (3) (4) (5) . Proto-oncogene c-fos and c-jun are known to code for the transcription factor AP-1 by forming a heterodimeric complex between Fos and Jun proteins and the formation of AP1 by these two oncoproteins is necessary for DNA binding, gene activation, cell cycle progression, cell proliferation and differentiation (5) (6) (7) (8) . Expression of these immediate early genes is also considered as a response to adverse stimuli and a molecular control of gene activation following genotoxic stress (5, 9) . A wide variety of environmental factors such as chemical carcinogens, tumor promoters, ionizing radiation and UV light have been demonstrated to stimulate expression of these immediate early genes in various types of cells as well as to increase transcript levels of c-fos, c-jun and c-myc in mouse skin (5) (6) (7) (8) (9) (10) (11) . DNA damaging agents as well as reactive oxygen species (ROS) have been suggested to regulate the expression of protooncogenes such as c-fos, c-jun and c-myc, suggesting that DNA damage plays an important role in the regulation of these immediate early genes (12) (13) (14) .
Genistein is an isoflavone present in large quantities (1-2 mg/g) in soybeans. In recent years, genistein has attracted wide attention for its specific inhibition of TPK and various anticancer properties (15, 16) . Genistein specifically inhibits the growth of ras-oncogene transfected NIH 3T3 cells (17) and diminishes PDGF-induced c-fos and c-jun expression in fibroblasts (18) . In addition, genistein inhibits topoisomerase II and ribosomal S6 kinase by stabilizing a cleavable enzyme-DNA complex and modulating mRNA translation in vitro, which may lead to protein-linked DNA strand breaks and growth suppression of several malignant cell lines (19) (20) (21) (22) . Genistein is also found to suppress the proliferation of a variety of human gastrointestinal cancer cell lines (23) , induce differentiation of leukemia cells (24) and inhibit endothelial cell angiogenesis relevant to tumor metastasis (25) . Recently, Uckun et al. (26) reported that the biotherapy potencies of B-cell precursor leukemia are tremendously increased by targeting genistein to CD 19-associated tyrosine kinases. We previously reported that genistein has been shown to inhibit 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced hydrogen peroxide production, proto-oncogene expression and skin tumor promotion in two-stage carcinogenesis (11, 27, 28) . Recently, we reported that genistein protected UV light-and Fenton reaction-induced oxidative DNA damage (29) .
It is known that UV radiation is able to induce c-fos and c-jun expression in cultured cells as well as in skin tissues (9, 30, 31) . Although the biological significance of protooncogene expression upon UV radiation continues to be debated, UV-responsive gene expression is considered to be associated with cellular proliferation and differentiation, probably the tumor promoting activities (1) (2) (3) (4) (5) . In the present study, we hypothesize that genistein modulates UVB-activated TPK-dependent pathway by down-regulating phosphorylation of EGF-R, thereby inhibiting expression of c-fos and c-jun in vivo. To evaluate the potential of genistein as an antiphotocarcinogenic agent in vivo and the possible mechanism of action, we have investigated the effects of genistein on UVB-induced expression of c-jun and c-fos in mouse skin and phosphorylation of EGF-R in A431 cells.
Material and methods

Cell culture and UV irradiation
Human epidermoid carcinoma cells (A431) were cultured in serum-free medium double minimal Eagle's medium (DMEM) containing 25 mM HEPES, glutamine and 100 units/ml of penicillin/streptomycin (GIBCO, Long Island, NY). Cells were cultured in humidified atmospheric incubator at 37°C, pretreated with different concentrations of genistein for 60 min, washed twice with PBS and then irradiated with appropriate UVB doses. UV irradiation was conducted on monolayer cultures, using a source consisting of four Westinghouse FS-20 bulbs. The spectral emission of the source is predominantly UVB range (290-320 nm). The radiance at a target distance of 25 cm and doses of UVB were determined by an IL1700 International Light Research radiometer. It was reported that a small portion of UVC in unfiltered UVB lamp was responsible for certain biological events such as activation of kinases in cultured cells (32, 33) . Therefore, special care was taken to ensure a defined UV range in the experiments. A polystyrene filter were used to remove the wavelength shorter than 290 nm. Cells were harvested at appropriate times post-UV irradiation and samples prepared for the analyses of EGF-R phosphorylation.
Animal treatment and UV irradiation
Female Sencar mice, 6-7 weeks old, were purchased from Biological Testing Inc. (NCI, Frederick) and kept at the Mount Sinai Animal Facility under standard conditions (12-h light/12-h dark cycle, humidity at 50 Ϯ 15%, temperature 22 Ϯ 2°C and 12 air changes/h) for 1 week prior to the experimentation. Food and water were provided ad libitum. The dorsal hair of the mice was shaved with surgical clippers 48 h prior to treatment and UV irradiation. Only those at hair-growth resting phase were selected for the experiments. All reagents were topically applied to mouse skin in 0.2 ml of acetone. Mice were treated with different doses of genistein 60 min prior to or immediately after UVB radiation. The UVB doses used were 5 and 15 kJ/m 2 , respectively, equaling about 3 and 10 minimal erythematous dose of mouse skin (34, 35) . Mice were killed 1 h after UVB irradiation and mouse skin removed for analyses of c-fos and c-jun expression. Each experiment was repeated two or three times with three mice per treatment group.
Purification of mRNA from skin tissue
Epidermis from three mice was pooled and homogenized in 10 ml of extraction buffer (0.2 M NaCl, 0.2 M TrisβHCl, 1.5 mM MgCl 2 , 2% SDS, and 200 µg/ml proteinase K, pH 7.5). The homogenates were incubated at 45°C for 3 h, and then 0.6 ml of 5 M NaCl added (final concentration of 0.5 M). Oligo-dT was added to the homogenates (50 mg/sample) and incubated overnight with rocking rotation. The mixtures were centrifuged at 3000 g for 5 min and washed twice with binding buffer (0.5 M NaCl, 10 mM Tris-HCl, pH 7.5). The pellet was resuspended in 10 ml binding buffer and added to polypropylene columns (Bio-Rad, Richmond, CA). Columns were washed three times with 10 ml low salt buffer (0.1 M NaCl, 10 mM Tris-HCl, 0.1 mM EDTA, 0.2% SDS, pH 7.5). Finally, polyA ϩ RNA was eluted out with 3 ml of 10 mM Tris-HCl, pH 7.5, precipitated at -70°C for 1 h with 0.1 volume of 3 M NaOAc and 2 volumes of cold ethanol and pelleted by centrifugation at 10 000 rev/min (SS34 rotor) for 20 min. PolyA ϩ RNA was dissolved in the disrupting buffer (20 mM HEPES, 5 mM NaOAc, 1 mM EDTA, 50% formamide and 8% formaldehyde) and quantitated spectrophotometrically.
Analyses of c-fos and c-jun by Northern hybridization
A total of 3-5 µg polyA ϩ RNA was denatured by incubation at 55°C for 10 min, then added to 5 µl of loading buffer (360 µl formamide, 40 µl 20ϫMOPS, 130 µl 37% formaldehyde, 50 µl glycerol, 80 µl saturated bromophenol blue, and 90 µl DEPD-H 2 O), loaded onto an agarose/formaldehyde gel and electrophoresed in 1ϫMOPS/EDTA buffer for~3 h (70-80 V). After electrophoresis, the gel was soaked in 2ϫSSC for 30 min and then transferred to a nitrocellulose membrane. After completion of the transfer, the nitrocellulose membrane was baked at 80°C for 2 h, placed in a sealable bag containing 15-20 ml pre-hybridization solution (50% formamide, 5ϫDenhardt's solution, 5 ϫSSC, 1% SDS, and 100 µg/ml salmon sperm DNA), and incubated at 42°C for 4 h. The cDNA probes of c-fos, c-jun and cyclophilin were labeled using NE Blot TM Kit (New England Biolabs, Beverly, MA). Cyclophilin was used to quantitate the loading amount of mRNA sample in gel electrophoresis (36) . The labeled probes (~10 6 cpm/ml) were denatured (boiled for 5 min), then added to the hybridization bag and incubated at 42°C overnight. On the following day, the filter was washed with 2ϫSSC/0.1% SDS twice at room temperature for 15 min, followed by 1ϫSSC/0.1% SDS at 65°C for 30 min, and 0.5ϫSSC/0.1% SDS at 65°C for another 30 min. Autoradiographies of the Northern blot were visualized by exposing the filter to X-ray film at -70°C. The bands of c-fos, c-jun and cyclophilin RNA were quantitated using densitometry and the results are expressed as relative intensity versus the intensity of normalized house keeper gene cyclophilin.
Assay for phosphorylation of EGF-R Assay were assayed as described (37-39) with a mild modification. Briefly, cell were grown in 100-mm culture dishes and used 2 days after confluence. Genistein were introduced with serum-free medium 3 h prior to UV irradiation. After UVB exposure or sham irradiation, cells were regrown in original medium. At selected times, cells were rinsed twice and harvested on ice in the lysing buffer. Solution was centrifuged at 16 000 g at 4°C. Supernatant was collected and normalized for protein. The resulting supernatant was incubated at 4°C with the monoclonal mouse antibody (Upstate Biotechnology Inc., Lake Placid, NY) against both the internal and external domains of EGF-R for 4 h. The antigen-antibody complex was isolated using protein A-Sepharose (Sigma, St Louis, MO). After extensive washing, the pellets were resuspended in standard SDS loading buffer, boiled for 3 min and then electrophoresed on a 7.5% SDS-PAGE gel. Protein was then transferred to the nitrocellulose membranes, incubated with anti-phosphotyrosine and protein A-horseradish peroxidase, and detected by enhanced chemiluminescence (Amersham, IL). Equal protein loading was confirmed by immunoblotting of anti-human EGF-R antibody.
Results
Dose-response and time-course of UV-induced proto-oncogene expression
We first determined the dose-response and time-course of UVB-induced c-fos and c-jun mRNA expression in SENCAR mouse skin. Figure 1 shows the time course of c-fos and c-jun expression after mouse skin exposure to 15 kJ/m 2 of UVB. As reported by Zwiller et al. (18) , there are two c-jun mRNA fragments (2.7 and 3.2 kb, respectively), which is due to the presence of two polyadenylation signals. The results showed that both genes expressed immediately post-UV radiation, reached the maximum at 1 h and then gradually declined to the basal levels 24 h after UV radiation. It appeared that c-jun expression lasted longer. With time point set at 1 h post-UV exposure, the dose-response of UVB-induced c-fos expression was determined. Expression of c-fos and c-jun was substantially increased by UVB irradiation at doses of 5 and 15 kJ/m 2 and then the transcripts were decreased with the increasing UV dose above 15 kJ/m 2 (data not shown). Based on these experiments, UV doses of 5 or 15 kJ/m 2 and the post-exposure time of 1 h were selected for the aftermentioned studies. Figure 2 shows that topical genistein substantially inhibited UVB (15 kJ/m 2 )-induced expression of c-fos and c-jun mRNA in mouse skin in a dose-dependent manner. Genistein per se did not change c-fos or c-jun expression in mouse skin (data not shown). The effect of genistein on expression of these genes was further examined in mouse skin exposed to 5 kJ/m 2 and 15 kJ/m 2 of UVB ( Figure 3 ). Quantitation showed that topical application of 10 µmol genistein 60 min before UV exposure almost completely inhibited c-fos and c-jun expression by lowdose UVB (lane 3). Expression of c-fos and c-jun expression by high-dose UVB was also substantially reduced by 62 and 24%, respectively (lane 6). This experiment showed that preapplied genistein significantly blocked UVB-induced expression of both c-fos and c-jun in mouse skin and inhibition of c-fos expression by genistein is more pronounced than that of c-jun ( Figure 3B ).
Effect of pre-application of genistein on UV-induced protooncogene expression
Effect of post-application of genistein on UVB-induced protooncogene expression
To evaluate if genistein modulates proto-oncogene expression post-UV exposure, 10 µmol of genistein was topically applied to mouse skin immediately after exposure to 15 kJ/m 2 of UVB. Figure 4 showed the post-application of genistein inhibited both c-fos and c-jun expression induced by UVB radiation, but to a lesser extent compared to pre-application. In addition, there was no difference in the inhibition of c-fos compared to c-jun expression (18% versus 22%). 
Effect of genistein on UVB-induced phosphorylation of EGF-R
A431 cells were used to investigate the mechanism of action of genistein since this cell line has excessive EGF-R. Figure  5 showed that UVB irradiation of A431 cells at a dose of 0.8 kJ/m 2 substantially increased phosphorylation of EGF-R by 4.6-fold (lane 2). Co-incubation of cells with genistein significantly inhibited UVB-induced EGF-R phosphorylation in a dose-dependent manner. The inhibition of UVB-induced phosphorylation was consistent with the findings that genistein down-regulates the UV radiation and growth factor activated TPK activities (37, 38) .
Discussion
In the current study we have demonstrated that genistein substantially inhibited UVB-induced expression of c-fos and c-jun in mouse skin. Although the significance of UV radiation-induced expression of 'immediate early genes' remains speculative, Fos/Jun oncoproteins are considered to play an important role in cell cycling, cellular differentiation and proliferation (5) (6) (7) (8) . A number of adverse stimuli, including DNA damaging agent, ROS, ionizing radiation and UV light have been demonstrated to induce expression of these immediate early genes as well as cell transformation. Therefore, over-expression of c-fos and c-jun has been associated with carcinogenic processes, particularly tumor promotion (1-5). Our study showed that UVB-induced expressions of c-fos and c-jun in mouse skin are blocked not only by pre-application, but also by post-application of genistein, suggesting that genistein may serve as a preventive agent against photocarcinogenesis.
Questions could be raised as to how genistein modulates UV-induced c-fos and c-jun expression. First of all, the 'sun-652 screen' effect of genistein should be ruled out. The maximum absorption of genistein is 262 nm and does not overlap with the selected UVB spectrum (280-320 nm). Furthermore, we have demonstrated that genistein selectively blocked UVBinduced H 2 O 2 production, lipid peroxidation and oxidative DNA without affecting UVB-mediated pyrimidine dimer formation and ornithine decarboxylate induction (manuscript in preparation). Thus, the 'sun-screen' effect should be minimal if there are any because sun-screening agents would block all UV responses without selection. Secondly, what is the mechanism of action by which genistein inhibits UVB-induced c-fos and c-jun expression in vivo. It is noted that the inhibition of UVB-induced proto-oncogene expression was quite different from that of TPA-induced gene expression. We previously demonstrated that genistein significantly inhibited TPA-induced c-fos, but not c-jun expression (11) . In the present study, genistein was shown to inhibit both c-fos and c-jun expression induced by UVB irradiation, although the inhibition of c-fos was more pronounced than that of c-jun. This differential action of genistein on UVB-and TPA-induced proto-oncogene may be due to different signal transduction pathways upstream the formation of transcription factor AP-1. It is well known that TPA exerts its action mainly through PKC or mitogenactivated protein (MAP) kinase, leading to phosphorylation of serine and threonine, whereas UV radiation activates both PKC and TPK pathways (1) (2) (3) (4) (5) (6) .
Genistein has been shown to down-regulate TPK activities caused by several activators, such as EGF and PDGF and viral oncogene products (e.g. pp 60 v-src and pp 110 gag-fes ), but only exhibited a minimal inhibition of PKC with IC 50 Ͼ 100 µM (15, 18) . It is known that EGF-R constitutes TPKs that can be activated by UV irradiation (1) (2) (3) (4) (5) (37) (38) (39) . There is an overlapping effect of EGF and UV radiation on certain biochemical events in cultured cells. It is assumed that UVinduced phosphorylation of EGF-R may mimic the EGF interaction that leads to phosphorylation of substrate such as phospholipid C and initiates a cascade of signal transduction. UV exposure has been shown to increase phospholipase activity, elevate prostaglandin synthesis and cause inflammatory responses (38, 39) . On the other hand, activation of TPK may sequentially activate downstream expression of c-fos and c-jun and lead to the formation of transcriptional factor AP-1. These biochemical events may cause the cellular proliferation and probably the tumor promotion as well. Since genistein is a specific TPK inhibitor, the initial action of genistein is assumed to modulate UV-activated TPK activities. However, there are some difficulties to investigate the mechanisms of action using in vivo models since the interactions between cell types or other components constitute a complexity that may mask the crucial events in the target cells or organs. Some biochemical events such as kinase activation occurs only transiently (usually within a few minutes) upon the stimulation. The information may be lost during isolation of cells and preparation of samples. Therefore, A431 cells were used to investigate the mechanism of action of genistein. In our study, UVB-induced phosphorylation of EGF-R was substantially down-regulated by genistein. The anti-TPK activity of genistein is also considered to be responsible for specific inhibition of ras-transfected NIH 3T3 cell growth (17) , suppression of PDGF-induced expression of c-fos and c-jun in fibroblasts (18) and blockage of UV-induced prostaglandin synthesis and release (38) and ROS-induced proto-oncogene expression (40, 41) . Since EGF-receptor contains the intrinsic TPK activities, genistein may exert its full suppression of gene expression through the down-regulating TPK activities as well as EGF-R phosphorylation.
Another possible mechanism of action is the antioxidant activity of genistein. Activation of TPK and MAP kinases by phorbol ester, ionizing radiation, UV light and hydrogen peroxide has been found to be through the formation of reactive oxygen intermediates because activation of TPK and MAP kinases can be inhibited by antioxidants (40) (41) (42) (43) (44) . Our previous studies have shown that genistein per se is a potent antioxidant that inhibits the production of H 2 O 2 in neutrophils, HL-60 cells, and mouse skin as well as superoxide anion production by xanthine/xanthine oxidase (27, 28) . Therefore, a question can be raised as to how to distinguish the direct anti-TPK activity from the indirect antioxidant properties, particularly related to the activation of TPK or inhibition of tyrosine phosphatase. It is well known that ROS per se inhibits tyrosine phosphatases, which may lead to impaired dephosphorylation of target proteins, such as EGF-R. The mixed effect could be separated by using the synthetic TPK inhibitors without antioxidant activities. Recently, DeLeo's laboratory has demonstrated that a synthetic TPK inhibitor Tyrphostin A47 without antioxidant properties blocked UVR-induced phosphorylation of EGF-R as genistein did (44) . Of course, further studies should be designed to investigate if more or less specific ROS scavengers (SOD for superoxide anion, catalase for H 2 O 2 and sodium azide for singlet oxygen) affects UVinduced TPK activation and EGF-R phosphorylation. These experiments will provide additional mechanistic insights of genistein's action.
In summary, we have demonstrated that genistein substan-653 tially inhibited UVB-induced c-fos and c-jun expression in vivo in a dose-dependent manner. The mechanism of action is probably mediated through modulation of TPK-dependent pathway. Down-regulation of UVR-induced EGF-R phosphorylation and proto-oncogene expression by genistein may suggest its modulation of tumor promotion. Indeed, our pilot animal studies indicated that genistein potently inhibited UVBinitiated and promoted skin tumorigenesis in SHK hairless mice (45) , suggesting that genistein may be used as a chemopreventive agent against UV-induced skin carcinogenesis.
